Report #2826948

Received Feb 19, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: NC
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	—	—

Symptoms (1)

Product preparation issue

Symptom narrative

administration of only the diluent portion; administration of only the diluent portion; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: administration of only the diluent portion) and inappropriate dose of vaccine administered (Verbatim: administration of only the diluent portion). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown. Additional Information: GSK receipt date: 28-JAN-2025 The pharmacist asked if it was problematic to administer only the diluent portion of Shingrix. The pharmacist was administered only diluent portion of Shingrix which led to, inappropriate preparation of medication and inappropriate dose of vaccine administered. The pharmacist was not sure if a patient received the diluent portion without the lyophilized component.